+1 347 708 0418
Immunity Nutraceutical Ingredient market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Immunity Nutraceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Minerals
Omega-3 fatty acids
Carotenoids
Fibers & specialty carbohydrates
Phytochemical and plant extracts
Others
Segment by Application
Functional food
Functional beverages
Dietary supplements
Animal nutrition
Personal care
By Company
Koninklijke DSM N.V. (Netherlands)
Ingredion Incorporated (U.S)
Ajinomoto Co., Inc. (Japan)
Arla Foods (Denmark)
Tate & Lyle PLC (U.K)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Immunity Nutraceutical Ingredient Product Introduction
1.2 Market by Type
1.2.1 Global Immunity Nutraceutical Ingredient Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Minerals
1.2.3 Omega-3 fatty acids
1.2.4 Carotenoids
1.2.5 Fibers & specialty carbohydrates
1.2.6 Phytochemical and plant extracts
1.2.7 Others
1.3 Market by Application
1.3.1 Global Immunity Nutraceutical Ingredient Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Functional food
1.3.3 Functional beverages
1.3.4 Dietary supplements
1.3.5 Animal nutrition
1.3.6 Personal care
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Immunity Nutraceutical Ingredient Sales Estimates and Forecasts 2017-2028
2.2 Global Immunity Nutraceutical Ingredient Revenue Estimates and Forecasts 2017-2028
2.3 Global Immunity Nutraceutical Ingredient Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Immunity Nutraceutical Ingredient Sales by Region
2.4.1 Global Immunity Nutraceutical Ingredient Sales by Region (2017-2022)
2.4.2 Global Sales Immunity Nutraceutical Ingredient by Region (2023-2028)
2.5 Global Immunity Nutraceutical Ingredient Revenue by Region
2.5.1 Global Immunity Nutraceutical Ingredient Revenue by Region (2017-2022)
2.5.2 Global Immunity Nutraceutical Ingredient Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Immunity Nutraceutical Ingredient Sales by Manufacturers
3.1.1 Global Top Immunity Nutraceutical Ingredient Manufacturers by Sales (2017-2022)
3.1.2 Global Immunity Nutraceutical Ingredient Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunity Nutraceutical Ingredient in 2021
3.2 Global Immunity Nutraceutical Ingredient Revenue by Manufacturers
3.2.1 Global Immunity Nutraceutical Ingredient Revenue by Manufacturers (2017-2022)
3.2.2 Global Immunity Nutraceutical Ingredient Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Immunity Nutraceutical Ingredient Revenue in 2021
3.3 Global Immunity Nutraceutical Ingredient Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Immunity Nutraceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Immunity Nutraceutical Ingredient Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Immunity Nutraceutical Ingredient Sales by Type
4.1.1 Global Immunity Nutraceutical Ingredient Historical Sales by Type (2017-2022)
4.1.2 Global Immunity Nutraceutical Ingredient Forecasted Sales by Type (2023-2028)
4.1.3 Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2017-2028)
4.2 Global Immunity Nutraceutical Ingredient Revenue by Type
4.2.1 Global Immunity Nutraceutical Ingredient Historical Revenue by Type (2017-2022)
4.2.2 Global Immunity Nutraceutical Ingredient Forecasted Revenue by Type (2023-2028)
4.2.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2017-2028)
4.3 Global Immunity Nutraceutical Ingredient Price by Type
4.3.1 Global Immunity Nutraceutical Ingredient Price by Type (2017-2022)
4.3.2 Global Immunity Nutraceutical Ingredient Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Immunity Nutraceutical Ingredient Sales by Application
5.1.1 Global Immunity Nutraceutical Ingredient Historical Sales by Application (2017-2022)
5.1.2 Global Immunity Nutraceutical Ingredient Forecasted Sales by Application (2023-2028)
5.1.3 Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2017-2028)
5.2 Global Immunity Nutraceutical Ingredient Revenue by Application
5.2.1 Global Immunity Nutraceutical Ingredient Historical Revenue by Application (2017-2022)
5.2.2 Global Immunity Nutraceutical Ingredient Forecasted Revenue by Application (2023-2028)
5.2.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2017-2028)
5.3 Global Immunity Nutraceutical Ingredient Price by Application
5.3.1 Global Immunity Nutraceutical Ingredient Price by Application (2017-2022)
5.3.2 Global Immunity Nutraceutical Ingredient Price Forecast by Application (2023-2028)
6 North America
6.1 North America Immunity Nutraceutical Ingredient Market Size by Type
6.1.1 North America Immunity Nutraceutical Ingredient Sales by Type (2017-2028)
6.1.2 North America Immunity Nutraceutical Ingredient Revenue by Type (2017-2028)
6.2 North America Immunity Nutraceutical Ingredient Market Size by Application
6.2.1 North America Immunity Nutraceutical Ingredient Sales by Application (2017-2028)
6.2.2 North America Immunity Nutraceutical Ingredient Revenue by Application (2017-2028)
6.3 North America Immunity Nutraceutical Ingredient Market Size by Country
6.3.1 North America Immunity Nutraceutical Ingredient Sales by Country (2017-2028)
6.3.2 North America Immunity Nutraceutical Ingredient Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Immunity Nutraceutical Ingredient Market Size by Type
7.1.1 Europe Immunity Nutraceutical Ingredient Sales by Type (2017-2028)
7.1.2 Europe Immunity Nutraceutical Ingredient Revenue by Type (2017-2028)
7.2 Europe Immunity Nutraceutical Ingredient Market Size by Application
7.2.1 Europe Immunity Nutraceutical Ingredient Sales by Application (2017-2028)
7.2.2 Europe Immunity Nutraceutical Ingredient Revenue by Application (2017-2028)
7.3 Europe Immunity Nutraceutical Ingredient Market Size by Country
7.3.1 Europe Immunity Nutraceutical Ingredient Sales by Country (2017-2028)
7.3.2 Europe Immunity Nutraceutical Ingredient Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Immunity Nutraceutical Ingredient Market Size by Type
8.1.1 Asia Pacific Immunity Nutraceutical Ingredient Sales by Type (2017-2028)
8.1.2 Asia Pacific Immunity Nutraceutical Ingredient Revenue by Type (2017-2028)
8.2 Asia Pacific Immunity Nutraceutical Ingredient Market Size by Application
8.2.1 Asia Pacific Immunity Nutraceutical Ingredient Sales by Application (2017-2028)
8.2.2 Asia Pacific Immunity Nutraceutical Ingredient Revenue by Application (2017-2028)
8.3 Asia Pacific Immunity Nutraceutical Ingredient Market Size by Region
8.3.1 Asia Pacific Immunity Nutraceutical Ingredient Sales by Region (2017-2028)
8.3.2 Asia Pacific Immunity Nutraceutical Ingredient Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Immunity Nutraceutical Ingredient Market Size by Type
9.1.1 Latin America Immunity Nutraceutical Ingredient Sales by Type (2017-2028)
9.1.2 Latin America Immunity Nutraceutical Ingredient Revenue by Type (2017-2028)
9.2 Latin America Immunity Nutraceutical Ingredient Market Size by Application
9.2.1 Latin America Immunity Nutraceutical Ingredient Sales by Application (2017-2028)
9.2.2 Latin America Immunity Nutraceutical Ingredient Revenue by Application (2017-2028)
9.3 Latin America Immunity Nutraceutical Ingredient Market Size by Country
9.3.1 Latin America Immunity Nutraceutical Ingredient Sales by Country (2017-2028)
9.3.2 Latin America Immunity Nutraceutical Ingredient Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Immunity Nutraceutical Ingredient Market Size by Type
10.1.1 Middle East and Africa Immunity Nutraceutical Ingredient Sales by Type (2017-2028)
10.1.2 Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Type (2017-2028)
10.2 Middle East and Africa Immunity Nutraceutical Ingredient Market Size by Application
10.2.1 Middle East and Africa Immunity Nutraceutical Ingredient Sales by Application (2017-2028)
10.2.2 Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Application (2017-2028)
10.3 Middle East and Africa Immunity Nutraceutical Ingredient Market Size by Country
10.3.1 Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2017-2028)
10.3.2 Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Koninklijke DSM N.V. (Netherlands)
11.1.1 Koninklijke DSM N.V. (Netherlands) Corporation Information
11.1.2 Koninklijke DSM N.V. (Netherlands) Overview
11.1.3 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Koninklijke DSM N.V. (Netherlands) Recent Developments
11.2 Ingredion Incorporated (U.S)
11.2.1 Ingredion Incorporated (U.S) Corporation Information
11.2.2 Ingredion Incorporated (U.S) Overview
11.2.3 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ingredion Incorporated (U.S) Recent Developments
11.3 Ajinomoto Co., Inc. (Japan)
11.3.1 Ajinomoto Co., Inc. (Japan) Corporation Information
11.3.2 Ajinomoto Co., Inc. (Japan) Overview
11.3.3 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ajinomoto Co., Inc. (Japan) Recent Developments
11.4 Arla Foods (Denmark)
11.4.1 Arla Foods (Denmark) Corporation Information
11.4.2 Arla Foods (Denmark) Overview
11.4.3 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Arla Foods (Denmark) Recent Developments
11.5 Tate & Lyle PLC (U.K)
11.5.1 Tate & Lyle PLC (U.K) Corporation Information
11.5.2 Tate & Lyle PLC (U.K) Overview
11.5.3 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tate & Lyle PLC (U.K) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Immunity Nutraceutical Ingredient Industry Chain Analysis
12.2 Immunity Nutraceutical Ingredient Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunity Nutraceutical Ingredient Production Mode & Process
12.4 Immunity Nutraceutical Ingredient Sales and Marketing
12.4.1 Immunity Nutraceutical Ingredient Sales Channels
12.4.2 Immunity Nutraceutical Ingredient Distributors
12.5 Immunity Nutraceutical Ingredient Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Immunity Nutraceutical Ingredient Industry Trends
13.2 Immunity Nutraceutical Ingredient Market Drivers
13.3 Immunity Nutraceutical Ingredient Market Challenges
13.4 Immunity Nutraceutical Ingredient Market Restraints
14 Key Findings in The Global Immunity Nutraceutical Ingredient Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Immunity Nutraceutical Ingredient Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Minerals
Table 3. Major Manufacturers of Omega-3 fatty acids
Table 4. Major Manufacturers of Carotenoids
Table 5. Major Manufacturers of Fibers & specialty carbohydrates
Table 6. Major Manufacturers of Phytochemical and plant extracts
Table 7. Major Manufacturers of Others
Table 8. Global Immunity Nutraceutical Ingredient Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Immunity Nutraceutical Ingredient Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Immunity Nutraceutical Ingredient Sales by Region (2017-2022) & (MT)
Table 11. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2017-2022)
Table 12. Global Immunity Nutraceutical Ingredient Sales by Region (2023-2028) & (MT)
Table 13. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2023-2028)
Table 14. Global Immunity Nutraceutical Ingredient Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2017-2022)
Table 16. Global Immunity Nutraceutical Ingredient Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2023-2028)
Table 18. Global Immunity Nutraceutical Ingredient Sales by Manufacturers (2017-2022) & (MT)
Table 19. Global Immunity Nutraceutical Ingredient Sales Share by Manufacturers (2017-2022)
Table 20. Global Immunity Nutraceutical Ingredient Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Immunity Nutraceutical Ingredient Revenue Share by Manufacturers (2017-2022)
Table 22. Immunity Nutraceutical Ingredient Price by Manufacturers (2017-2022) &(USD/Kg)
Table 23. Global Immunity Nutraceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Immunity Nutraceutical Ingredient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunity Nutraceutical Ingredient as of 2021)
Table 25. Immunity Nutraceutical Ingredient Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Immunity Nutraceutical Ingredient Product Offered
Table 27. Date of Manufacturers Enter into Immunity Nutraceutical Ingredient Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Immunity Nutraceutical Ingredient Sales by Type (2017-2022) & (MT)
Table 30. Global Immunity Nutraceutical Ingredient Sales by Type (2023-2028) & (MT)
Table 31. Global Immunity Nutraceutical Ingredient Sales Share by Type (2017-2022)
Table 32. Global Immunity Nutraceutical Ingredient Sales Share by Type (2023-2028)
Table 33. Global Immunity Nutraceutical Ingredient Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Immunity Nutraceutical Ingredient Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Immunity Nutraceutical Ingredient Revenue Share by Type (2017-2022)
Table 36. Global Immunity Nutraceutical Ingredient Revenue Share by Type (2023-2028)
Table 37. Immunity Nutraceutical Ingredient Price by Type (2017-2022) & (USD/Kg)
Table 38. Global Immunity Nutraceutical Ingredient Price Forecast by Type (2023-2028) & (USD/Kg)
Table 39. Global Immunity Nutraceutical Ingredient Sales by Application (2017-2022) & (MT)
Table 40. Global Immunity Nutraceutical Ingredient Sales by Application (2023-2028) & (MT)
Table 41. Global Immunity Nutraceutical Ingredient Sales Share by Application (2017-2022)
Table 42. Global Immunity Nutraceutical Ingredient Sales Share by Application (2023-2028)
Table 43. Global Immunity Nutraceutical Ingredient Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Immunity Nutraceutical Ingredient Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Immunity Nutraceutical Ingredient Revenue Share by Application (2017-2022)
Table 46. Global Immunity Nutraceutical Ingredient Revenue Share by Application (2023-2028)
Table 47. Immunity Nutraceutical Ingredient Price by Application (2017-2022) & (USD/Kg)
Table 48. Global Immunity Nutraceutical Ingredient Price Forecast by Application (2023-2028) & (USD/Kg)
Table 49. North America Immunity Nutraceutical Ingredient Sales by Type (2017-2022) & (MT)
Table 50. North America Immunity Nutraceutical Ingredient Sales by Type (2023-2028) & (MT)
Table 51. North America Immunity Nutraceutical Ingredient Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Immunity Nutraceutical Ingredient Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Immunity Nutraceutical Ingredient Sales by Application (2017-2022) & (MT)
Table 54. North America Immunity Nutraceutical Ingredient Sales by Application (2023-2028) & (MT)
Table 55. North America Immunity Nutraceutical Ingredient Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Immunity Nutraceutical Ingredient Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Immunity Nutraceutical Ingredient Sales by Country (2017-2022) & (MT)
Table 58. North America Immunity Nutraceutical Ingredient Sales by Country (2023-2028) & (MT)
Table 59. North America Immunity Nutraceutical Ingredient Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Immunity Nutraceutical Ingredient Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Immunity Nutraceutical Ingredient Sales by Type (2017-2022) & (MT)
Table 62. Europe Immunity Nutraceutical Ingredient Sales by Type (2023-2028) & (MT)
Table 63. Europe Immunity Nutraceutical Ingredient Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Immunity Nutraceutical Ingredient Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Immunity Nutraceutical Ingredient Sales by Application (2017-2022) & (MT)
Table 66. Europe Immunity Nutraceutical Ingredient Sales by Application (2023-2028) & (MT)
Table 67. Europe Immunity Nutraceutical Ingredient Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Immunity Nutraceutical Ingredient Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Immunity Nutraceutical Ingredient Sales by Country (2017-2022) & (MT)
Table 70. Europe Immunity Nutraceutical Ingredient Sales by Country (2023-2028) & (MT)
Table 71. Europe Immunity Nutraceutical Ingredient Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Immunity Nutraceutical Ingredient Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Immunity Nutraceutical Ingredient Sales by Type (2017-2022) & (MT)
Table 74. Asia Pacific Immunity Nutraceutical Ingredient Sales by Type (2023-2028) & (MT)
Table 75. Asia Pacific Immunity Nutraceutical Ingredient Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Immunity Nutraceutical Ingredient Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Immunity Nutraceutical Ingredient Sales by Application (2017-2022) & (MT)
Table 78. Asia Pacific Immunity Nutraceutical Ingredient Sales by Application (2023-2028) & (MT)
Table 79. Asia Pacific Immunity Nutraceutical Ingredient Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Immunity Nutraceutical Ingredient Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Immunity Nutraceutical Ingredient Sales by Region (2017-2022) & (MT)
Table 82. Asia Pacific Immunity Nutraceutical Ingredient Sales by Region (2023-2028) & (MT)
Table 83. Asia Pacific Immunity Nutraceutical Ingredient Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Immunity Nutraceutical Ingredient Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Immunity Nutraceutical Ingredient Sales by Type (2017-2022) & (MT)
Table 86. Latin America Immunity Nutraceutical Ingredient Sales by Type (2023-2028) & (MT)
Table 87. Latin America Immunity Nutraceutical Ingredient Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Immunity Nutraceutical Ingredient Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Immunity Nutraceutical Ingredient Sales by Application (2017-2022) & (MT)
Table 90. Latin America Immunity Nutraceutical Ingredient Sales by Application (2023-2028) & (MT)
Table 91. Latin America Immunity Nutraceutical Ingredient Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Immunity Nutraceutical Ingredient Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Immunity Nutraceutical Ingredient Sales by Country (2017-2022) & (MT)
Table 94. Latin America Immunity Nutraceutical Ingredient Sales by Country (2023-2028) & (MT)
Table 95. Latin America Immunity Nutraceutical Ingredient Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Immunity Nutraceutical Ingredient Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Immunity Nutraceutical Ingredient Sales by Type (2017-2022) & (MT)
Table 98. Middle East and Africa Immunity Nutraceutical Ingredient Sales by Type (2023-2028) & (MT)
Table 99. Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Immunity Nutraceutical Ingredient Sales by Application (2017-2022) & (MT)
Table 102. Middle East and Africa Immunity Nutraceutical Ingredient Sales by Application (2023-2028) & (MT)
Table 103. Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2017-2022) & (MT)
Table 106. Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2023-2028) & (MT)
Table 107. Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Immunity Nutraceutical Ingredient Revenue by Country (2023-2028) & (US$ Million)
Table 109. Koninklijke DSM N.V. (Netherlands) Corporation Information
Table 110. Koninklijke DSM N.V. (Netherlands) Description and Major Businesses
Table 111. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 112. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Koninklijke DSM N.V. (Netherlands) Recent Developments
Table 114. Ingredion Incorporated (U.S) Corporation Information
Table 115. Ingredion Incorporated (U.S) Description and Major Businesses
Table 116. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 117. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Ingredion Incorporated (U.S) Recent Developments
Table 119. Ajinomoto Co., Inc. (Japan) Corporation Information
Table 120. Ajinomoto Co., Inc. (Japan) Description and Major Businesses
Table 121. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 122. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Ajinomoto Co., Inc. (Japan) Recent Developments
Table 124. Arla Foods (Denmark) Corporation Information
Table 125. Arla Foods (Denmark) Description and Major Businesses
Table 126. Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 127. Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Arla Foods (Denmark) Recent Developments
Table 129. Tate & Lyle PLC (U.K) Corporation Information
Table 130. Tate & Lyle PLC (U.K) Description and Major Businesses
Table 131. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 132. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Tate & Lyle PLC (U.K) Recent Developments
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Immunity Nutraceutical Ingredient Distributors List
Table 137. Immunity Nutraceutical Ingredient Customers List
Table 138. Immunity Nutraceutical Ingredient Market Trends
Table 139. Immunity Nutraceutical Ingredient Market Drivers
Table 140. Immunity Nutraceutical Ingredient Market Challenges
Table 141. Immunity Nutraceutical Ingredient Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunity Nutraceutical Ingredient Product Picture
Figure 3. Global Immunity Nutraceutical Ingredient Market Share by Type in 2021 & 2028
Figure 3. Minerals Product Picture
Figure 4. Omega-3 fatty acids Product Picture
Figure 5. Carotenoids Product Picture
Figure 6. Fibers & specialty carbohydrates Product Picture
Figure 7. Phytochemical and plant extracts Product Picture
Figure 8. Others Product Picture
Figure 9. Global Immunity Nutraceutical Ingredient Market Share by Application in 2021 & 2028
Figure 10. Functional food
Figure 11. Functional beverages
Figure 12. Dietary supplements
Figure 13. Animal nutrition
Figure 14. Personal care
Figure 15. Immunity Nutraceutical Ingredient Report Years Considered
Figure 16. Global Immunity Nutraceutical Ingredient Sales 2017-2028 (MT)
Figure 17. Global Immunity Nutraceutical Ingredient Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Immunity Nutraceutical Ingredient Revenue 2017-2028 (US$ Million)
Figure 19. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2017-2022)
Figure 21. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2023-2028)
Figure 22. North America Immunity Nutraceutical Ingredient Sales YoY (2017-2028) & (MT)
Figure 23. North America Immunity Nutraceutical Ingredient Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Immunity Nutraceutical Ingredient Sales YoY (2017-2028) & (MT)
Figure 25. Europe Immunity Nutraceutical Ingredient Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Immunity Nutraceutical Ingredient Sales YoY (2017-2028) & (MT)
Figure 27. Asia-Pacific Immunity Nutraceutical Ingredient Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Immunity Nutraceutical Ingredient Sales YoY (2017-2028) & (MT)
Figure 29. Latin America Immunity Nutraceutical Ingredient Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Immunity Nutraceutical Ingredient Sales YoY (2017-2028) & (MT)
Figure 31. Middle East & Africa Immunity Nutraceutical Ingredient Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Immunity Nutraceutical Ingredient Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Immunity Nutraceutical Ingredient in the World: Market Share by Immunity Nutraceutical Ingredient Revenue in 2021
Figure 34. Global Immunity Nutraceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 36. Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2017-2028)
Figure 37. Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 38. Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2017-2028)
Figure 39. North America Immunity Nutraceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 40. North America Immunity Nutraceutical Ingredient Revenue Market Share by Type (2017-2028)
Figure 41. North America Immunity Nutraceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 42. North America Immunity Nutraceutical Ingredient Revenue Market Share by Application (2017-2028)
Figure 43. North America Immunity Nutraceutical Ingredient Sales Share by Country (2017-2028)
Figure 44. North America Immunity Nutraceutical Ingredient Revenue Share by Country (2017-2028)
Figure 45. U.S. Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Immunity Nutraceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 48. Europe Immunity Nutraceutical Ingredient Revenue Market Share by Type (2017-2028)
Figure 49. Europe Immunity Nutraceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 50. Europe Immunity Nutraceutical Ingredient Revenue Market Share by Application (2017-2028)
Figure 51. Europe Immunity Nutraceutical Ingredient Sales Share by Country (2017-2028)
Figure 52. Europe Immunity Nutraceutical Ingredient Revenue Share by Country (2017-2028)
Figure 53. Germany Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 54. France Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Immunity Nutraceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Immunity Nutraceutical Ingredient Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Immunity Nutraceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Immunity Nutraceutical Ingredient Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Immunity Nutraceutical Ingredient Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Immunity Nutraceutical Ingredient Revenue Share by Region (2017-2028)
Figure 64. China Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 67. India Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Immunity Nutraceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 75. Latin America Immunity Nutraceutical Ingredient Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Immunity Nutraceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 77. Latin America Immunity Nutraceutical Ingredient Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Immunity Nutraceutical Ingredient Sales Share by Country (2017-2028)
Figure 79. Latin America Immunity Nutraceutical Ingredient Revenue Share by Country (2017-2028)
Figure 80. Mexico Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Immunity Nutraceutical Ingredient Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Immunity Nutraceutical Ingredient Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Immunity Nutraceutical Ingredient Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Immunity Nutraceutical Ingredient Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Immunity Nutraceutical Ingredient Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Immunity Nutraceutical Ingredient Revenue Share by Country (2017-2028)
Figure 89. Turkey Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 91. U.A.E Immunity Nutraceutical Ingredient Revenue (2017-2028) & (US$ Million)
Figure 92. Immunity Nutraceutical Ingredient Value Chain
Figure 93. Immunity Nutraceutical Ingredient Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Buy
